Literature DB >> 24958704

Update on the disease burden and circulating strains of rotavirus in China: a systematic review and meta-analysis.

Na Liu1, Ziqian Xu1, Dandi Li1, Qing Zhang1, Hong Wang1, Zhao-Jun Duan2.   

Abstract

BACKGROUND: Rotavirus is the most common cause of severe diarrhea in children, and most associated deaths occur in developing countries. Two new internationally licensed vaccines are expected to be launched in the near future in China. We performed a systematic review and meta-analysis of rotavirus studies to update information on the burden of rotavirus disease in China.
MATERIALS AND METHODS: Eligible studies published before 2011 were identified using PubMed/Medline, Embase, Cochrane Library, LILACS, WHOLIS, and two Chinese literature databases, CNKI, and WANFANG. Arc-sine transformations and the DerSimonian-Laird random-effects or fixed-effects models were used for meta-analysis.
RESULTS: A total of 211 studies were included in this review, of which 63 (29.9%) were inpatient studies, 26 (12.3%) were outpatient, 122 (57.8%) were combined. Community subjects were investigated in two combined studies. Rates of gastroenteritis caused by rotavirus in inpatients, outpatients, and community children were 42.6%, 32.5% and 9.3%, respectively. The most common G type was G3 (39.3%), followed by G1 (30.3%), G2 (7.2%), and G9 (3.3%). The most common P types were P[8] (50.2%), P[4] (18.2%), and P[6] (7.2%). The most prevalent G-P combinations were G3P[8] (32.1%), G1P[8] (23.0%), and G2P[4] (7.9%).
CONCLUSION: Rotavirus is an important cause of both severe and mild diarrheal disease in children <5 years of age in China; G3P[8] is the most prevalent strain. The introduction of an effective rotavirus vaccine to Chinese pediatric immunization programs is necessary.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  China; Disease burden; Rotavirus; Strains

Mesh:

Year:  2014        PMID: 24958704     DOI: 10.1016/j.vaccine.2014.06.018

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infants.

Authors:  Zhiwei Wu; Qingliang Li; Yan Liu; Huakun Lv; Zhaojun Mo; Fangjun Li; Qingchuan Yu; Fei Jin; Wei Chen; Yong Zhang; Teng Huang; Xiaosong Hu; Wei Xia; Jiamei Gao; Haisong Zhou; Xuan Bai; Yueyue Liu; Zhenzhen Liang; Zhijun Jiang; Yingping Chen; Jiuwei Zhang; Jialiang Du; Biao Yang; Bo Xing; Yantao Xing; Ben Dong; Qinghai Yang; Chen Shi; Tingdong Yan; Bo Ruan; Haiyun Shi; Xingliang Fan; Dongyang Feng; Weigang Lv; Dong Zhang; Xiangchu Kong; Liuyifan Zhou; Dinghong Que; Hong Chen; Zhongbing Chen; Xiang Guo; Weiwei Zhou; Cong Wu; Qingrong Zhou; Yuqing Liu; Jian Qiao; Ying Wang; Xinguo Li; Kai Duan; Yuliang Zhao; Gelin Xu; Xiaoming Yang
Journal:  Virol Sin       Date:  2022-08-01       Impact factor: 6.947

2.  Glycan Binding Specificity and Mechanism of Human and Porcine P[6]/P[19] Rotavirus VP8*s.

Authors:  Xiaoman Sun; Dandi Li; Jianxun Qi; Wengang Chai; Luyao Wang; Lihong Wang; Ruchao Peng; Han Wang; Qing Zhang; Lili Pang; Xiangyu Kong; Hong Wang; Miao Jin; George F Gao; Zhaojun Duan
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

3.  Active, population-based surveillance for rotavirus gastroenteritis in Chinese children: Beijing Municipality and Gansu Province, China.

Authors:  Jing Zhang; Haixia Liu; Lei Jia; Daniel C Payne; Aron J Hall; Ziqian Xu; Zhiyong Gao; Zhaorui Chang; Baoming Jiang; Umesh D Parashar; Lei Meng; Hongjie Yu; Zhaojun Duan
Journal:  Pediatr Infect Dis J       Date:  2015-01       Impact factor: 2.129

4.  Preferences for vaccination program attributes among parents of young infants in Shanghai, China.

Authors:  Zhuoying Huang; Abram L Wagner; Muzi Lin; Xiaodong Sun; Brian J Zikmund-Fisher; Matthew L Boulton; Jia Ren; Lisa A Prosser
Journal:  Hum Vaccin Immunother       Date:  2020-01-24       Impact factor: 3.452

5.  Infection status and circulating strains of rotaviruses in Chinese children younger than 5-years old from 2011 to 2018: systematic review and meta-analysis.

Authors:  Jingxin Li; Hong Wang; Dandi Li; Qing Zhang; Na Liu
Journal:  Hum Vaccin Immunother       Date:  2021-03-02       Impact factor: 3.452

6.  Viral etiologies of acute dehydrating gastroenteritis in pakistani children: confounding role of parechoviruses.

Authors:  Muhammad Masroor Alam; Adnan Khurshid; Shahzad Shaukat; Muhammad Suleman Rana; Salmaan Sharif; Mehar Angez; Nadia Nisar; Uzma Bashir Aamir; Muhammad Naeem; Syed Sohail Zahoor Zaidi
Journal:  Viruses       Date:  2015-01-20       Impact factor: 5.048

7.  P[8] and P[4] Rotavirus Infection Associated with Secretor Phenotypes Among Children in South China.

Authors:  Xu-Fu Zhang; Yan Long; Ming Tan; Ting Zhang; Qiong Huang; Xi Jiang; Wen-Fang Tan; Jian-Dong Li; Gui-Fang Hu; Shixing Tang; Ying-Chun Dai
Journal:  Sci Rep       Date:  2016-10-06       Impact factor: 4.379

8.  Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design.

Authors:  Shan-Shan Zhen; Yue Li; Song-Mei Wang; Xin-Jiang Zhang; Zhi-Yong Hao; Ying Chen; Dan Wang; Yan-Hong Zhang; Zhi-Yong Zhang; Jing-Chen Ma; Peng Zhou; Zhen Zhang; Zhi-Wei Jiang; Yu-Liang Zhao; Xuan-Yi Wang
Journal:  Emerg Microbes Infect       Date:  2015-10-28       Impact factor: 7.163

9.  Continuous detection and genetic diversity of human rotavirus A in sewage in eastern China, 2013-2014.

Authors:  Nan Zhou; Dong Lv; Suting Wang; Xiaojuan Lin; Zhenwang Bi; Haiyan Wang; Pei Wang; Huaning Zhang; Zexin Tao; Peibin Hou; Yanyan Song; Aiqiang Xu
Journal:  Virol J       Date:  2016-09-13       Impact factor: 4.099

10.  Impact of co-infections with enteric pathogens on children suffering from acute diarrhea in southwest China.

Authors:  Shun-Xian Zhang; Yong-Ming Zhou; Wen Xu; Li-Guang Tian; Jia-Xu Chen; Shao-Hong Chen; Zhi-Sheng Dang; Wen-Peng Gu; Jian-Wen Yin; Emmanuel Serrano; Xiao-Nong Zhou
Journal:  Infect Dis Poverty       Date:  2016-06-27       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.